Abstract
Transcription factor Neurod1 is required for enteroendocrine progenitor differentiation and maturation. Several earlier studies indicated that ectopic expression of Neurod1 converted non- neuronal cells into neurons. However, the functional consequence of ectopic Neurod1 expression has not been examined in the GI tract, and it is not known whether Neurod1 can similarly switch cell fates in the intestine. We generated a mouse line that would enable us to conditionally express Neurod1 in intestinal epithelial cells at different stages of differentiation. Forced expression of Neurod1 throughout intestinal epithelium increased the number of EECs as well as the expression of EE specific transcription factors and hormones. Furthermore, we observed a substantial reduction of Paneth cell marker expression, although the expressions of enterocyte-, tuft- and goblet-cell specific markers are largely not affected. Our earlier study indicated that Neurog3+ progenitor cells give rise to not only EECs but also Goblet and Paneth cells. Here we show that the conditional expression of Neurod1 restricts Neurog3+ progenitors to adopt Paneth cell fate, and promotes more pronounced EE cell differentiation, while such effects are not seen in more differentiated Neurod1+ cells. Together, our data suggest that forced expression of Neurod1 programs intestinal epithelial cells more towards an EE cell fate at the expense of the Paneth cell lineage and the effect ceases as cells mature to EE cells.
Subject terms: Differentiation, Endocrine system and metabolic diseases
Introduction
Intestinal epithelial cells are divided into two main categories - absorptive cells and secretory cells. The absorptive cells include enterocytes and the secretory cells include enteroendocrine (EE), goblet, Paneth, and tuft cells1,2. All five cell types are derived from common multipotent intestinal stem cells. The expression of the atonal basic helix-loop-helix (bHLH) transcription factor 1 (Atoh1) initiates the differentiation of progenitor cells that are subsequently either fated to EE cell lineages by the downstream transcription factor, Neurogenin-3 (Neurog3, Ngn3), or to Goblet and Paneth cell lineages upon expression of the transcriptional repressor, growth factor independent-1(Gfi1)3–7. The differentiation of Tuft cells, on the other hand, adopts an Atoh1-independent pathway involving high expression of Sox48,9. EE cells are hormone-producing cells scattered individually throughout the mammalian gastrointestinal tract. These cells comprise less than 2% of the total cell population. The maturation and subtype specification of EE cells along crypt-villus axis require subsequent expression of a number of pro-endocrine transcription factors including Neurod1, Lmx1a, Nkx2-2, Insm1, Arx, Isl1 and Pax4/610–19.
The expression of Neurod1, a member of the bHLH family of transcription factors, is restricted to pancreatic islets, intestinal endocrine, stomach and neuronal cells. It regulates the expression of the insulin gene in pancreatic beta cells20,21, the secretin gene in small intestine22, and is capable to reprogram fibroblasts to a neuronal fate23–25 or Schwann cells into neurons26. In addition, Neurod1 (Nd1) also functions in governing cell cycle exit in photoreceptor lineage27 and can cause cell cycle arrest in in vitro cell culture28,29. Studies of Neurod1 targeted deletion mutants revealed its important functions in development and maintenance in several developing systems including the central nervous system30–33, the peripheral nervous systems (including the inner ear)34–37, the EE cells of the GI tract7,38,39, as well as the beta cells of the pancreas21,40. Neurod1 mutations have been found to cause maturity-onset diabetes of the young and late-onset diabetes (Online Mendelian Inheritance in Man 606394)41. Recently, Neurod1 null mutations have been linked to ophthalmological phenotypes in humans42.
Neurod1 is a direct transcriptional target of Neurog3 in intestinal EECs43,44. Early studies have shown that Neurog3 is sufficient to induce an endocrine program when expressed in the intestine of transgenic mice6. Recent single-cell RNA profiling of individual intestinal epithelial cells categorized both Neurog3 and Neurod1 as markers for immature45 or differentiating46 EEC precursors, suggesting a function of Neurod1 in early EEC differentiation. Another function of Neurod1 is its ability to reprogram other cell types into neurons through altering chromatin and transcription factor landscapes47. These results prompted us to investigate if expression of Neurod1 prior to Neurog3 can override the default function of Neurog3 in EE cell differentiation. To examine, we generated a Rosa26 Loxp-Stop-Loxp-Neurod1 (LSLNeurod1) mouse line that allows conditional Neurod1 expression in Villin + cells (prior to Neurog3) by crossing with Vil-cre mice or Neurog3 + cells (concomitant with Neurog3) by crossing with Neurog3-cre mice. In this manuscript, we provide data demonstrating that conditional gain-of-function of Neurod1 prior to Neurog3 expression robustly increases EE cell numbers and this differentiation process is limited to a subset of the gut progenitor cells that are competent to adopt an endocrine fate.
Results
Conditional expression of Neurod1 in the intestinal epithelial cells
To test if Neurod1 can switch cell fate and promote EEC differentiation in the developing intestinal epithelium, we generated a conditional gain-of-function Rosa26-loxp-Stop-loxp(LSL)Neurod1-IRES-eGFP mice line. A 1,280 bp full-length mouse Neurod1 cDNA was cloned into the pEntry vector (Gateway®, Life Science). The conditional Rosa26LSLNeurod1 targeting vector was created through recombination of the pROSA26-DV1 destination vector with pENTR-mNeurod1 and targeted to the Rosa26 locus by electroporation into JM8F6 (C57BL/6) mouse embryonic stem (ES) cells48. We identified 7 out of 36 correctly targeted ES clones by PCR analysis using primers that cover both Rosa26 genomic sequence and the inserted transgenes (Fig. 1A). Clone A1 was chosen for C57BL/6 blastocyst injection to generate chimeras for germline transmission. ROSA-Loxp-STOP-loxpNeurod1 (LSLNeurod1) conditional mice were born viable and fertile.
To determine whether LSLNeurod1 mice can be used to induce Neurod1 expression by Cre-mediated recombination in the small intestine, we crossed LSLNeurod1 mice with Villin-cre driver. Villin is expressed in most intestinal epithelial cells beginning at E13.549,50. Villin-cre-mediated excision of the Loxp-STOP-Loxp sequence allowed transcriptional read-through between the two LoxP sites in the Neurod1-IRES-eGFP bi-cistronic transgene, resulting in Neurod1 and EGFP expression. The expression of Neurod1 and EGFP transgenes were determined by qPCR for transcripts, and immunofluorescent microscopy and immunoblotting for Neurod1 protein. As shown in Fig. 1B, compared with control Vil-cre;ROSAEYFP (LSLEYFP) mice, Neurod1 transcript in intestinal epithelial cells increased ~4.4-fold in Vil-cre;LSLNeurod1 mice whereas EGFP expression level is much lower than that of Vil-cre;LSLEYFP mice (11%). This is consistent with earlier findings that genes downstream of IRES are expressed at lower levels compared with the genes upstream of the IRES51,52.
The Neurod1 and EG/YFP proteins in the intestine were detected by co-immunostaining with Neurod1 antibody and EGFP antibody which recognized both EGFP and EYFP proteins on duodenal tissues from Vil-cre;LSLEYFP and Vil-cre;LSLNeurod1 mice (Fig. 1C). As expected, we observed the green EYFP staining throughout crypt-villus structure of the intestine and sporadic Neurod1 nuclei staining (red arrow) in control Vil-cre;LSLEYFP mice (Fig. 1C, top left panel). In Vil-cre;LSLNeurod1 mice, we observed a significant increase in nuclear Neurod1-positive cells along the intestinal epithelium, mostly in the crypts from the duodenum (39% ± 11%) to the colon (32% ± 3%) (Fig. 1D). Approximately 10% of the Neurod1-positive cells appeared as epithelial ribbons in the crypt (Fig. 1C, bottom right panel). EGFP expression can be detected in both crypt and villi of those cells co-stained with Neurod1. We also analyzed proteins in whole cell lysates from Vilcre;LSLNeurod1 mouse intestine that are recognized by the Neurod1 antibody in a Western blotting analysis (Fig. 1E). The antibody detected a single protein band (molecular weight of 50 kDa, the size of Neurod1 protein) with little or no background, further consolidating the above Neurod1 immunostaining results (Supplemental Figure).
Neurod1 expression in Villin+ cells profoundly increases EE cell numbers
To determine if the conditional Neurod1-expressing cells in the intestine of Vil-cre;LSLNeurod1 mice were endocrine cells, we stained intestinal sections with a pan-endocrine marker Chromogranin A (ChgA)53. A substantial increase in the number of ChgA+ cells in both the duodenal (11.1×) and colonic (11×) epithelium were observed, compared to Vil-cre;LSLEYFP control mice (Fig. 2A). In some crypt-villus structures, the increased ChgA+ EGFP + cell number was more pronounced, with nearly all cells in the epithelium expressing ChgA. The increased EE cell population in Vil-cre;LSLNeurod1 mice suggested that Neurod1 is able to direct EEC differentiation when ectopically expressed. Contrary to sporadic appearance of EECs in the normal intestine, we observed ChgA+ EECs resided adjacent to each other (Fig. 2A,bottom right) in the intestines of Vil-cre;LSLNeurod1 mice, suggesting the loss of lateral inhibition function of Notch signaling by Neurod1, possibly through inhibiting Hes1 function54.
We next determined if Neurod1 increased the expression of genes associated with enteroendocrine function and differentiation by qPCR analysis. As shown in Fig. 2B, Neurod1 substantially increased the expression of many EEC hormones or associated genes including secretin (Sct), cholecystokinin (Cck), somatostatin (Sst), tryptophan hydroxylase 1 (Tph1), gastric inhibitory polypeptide (Gip), and ghrelin; whereas glucagon transcripts did not show much change. The expression of a number of transcription factors associated with endocrine differentiation in the GI tract, including Nkx2-2, Neurog3, Lmx1a, Insm1, Isl1 and Arx were found considerably increased along with Neurod1 (Fig. 2C), consistent with the increase of EEC numbers.
We examined the effects of Neurod1 on the expression of intestinal lineage specific genes including goblet cell (Muc2, Tff3, Klf4), enterocytes (ApoA4, Alpi, Fabp), Paneth cell (Lyz1, Dpp4) and Tuft cell (Dclk1, Siglec1) genes. qPCR assay shown in Fig. 3 revealed that the expression of Neurod1 in Villin+ cells had minimal effect on expressions of genes specific for enterocytes, goblet and Tuft cells. However, expression of the Paneth cell specific maker genes Lyz1 and Dpp4 were reduced by approximately 60% and 50% respectively. These results suggested that upon Neurod1 expression in Paneth cell progenitors, their maturation is either blocked or shunt towards EEC lineage, possibly via a well-known negative feedback loop of Neurod1 on controlling Atoh1 expression level in developing system55,56.
However, not all Neurod1 expressing cells were ChgA+ (Fig. 4A, green arrow). We observed a 54.4% ± 8% of cells stained for Neurod1 that co-stained with ChgA in the intestines of ROSA26-LStopLNeurod mice strain.
Neurod1 induction of the endocrine lineage depends on the differentiation stage
All five cell types in adult intestinal epithelium are constantly regenerated from multipotential ISCs. The expression of Neurog3 represents one of the earliest stages in the initiation of EEC specification whereas the subsequent expression of its target, Neurod1, occurs at a later stage of EEC differentiation when cells are restricted to an EEC cell fate7. To determine the effect of Neurod1 on cell fates in Neurog3+ early EEC progenitors or Neurod1+ late EEC precursors, we crossed ROSA-LSLNeurod1 mice with Neurog3-cre or Neurod1-cre mice respectively. As shown in Fig. 4, when Neurod1 expression was activated in Neurog3+ progenitor cells by the Neurog3-cre driver, we observed a small increase (~2 fold) in ChgA+ cell numbers. However, ectopic Neurod1 expression in Neurod1+ cells resulted in a 58% reduction of ChgA+ EEC numbers (Fig. 4B). This suggested a potential function of Neurod1 in promoting EEC differentiation and that may depend on the competency of the target progenitor cells.
Neurod1 expression in Neurog3 cells blocks their fate towards paneth cells
We further analyzed the cell fates of Neurod1+ expressing cells in the intestine of Neurog3-cre;LSLNeurod1 mice. Unlike Neurog3+ cells in Neurog3cre;ROSA-EYFP mice that give rise to all three types of secretory cells, including Paneth cells (~30%), goblet cells (~25%), and EEC cells (~40%)57, the Neurod1 expressing Neurog3+ cells in Neurog3-cre-LSLNeurod1 mice gave rise only to EEC and goblet cells (Fig. 5A, yellow arrow). Tuft cells, another secretory cell type present in the small intestine, differentiate from an Atoh1-independent origin8. We observed an increase of ChgA+ EEC cell numbers (77% for Neurog3cre;LSLNeurod1 and 36% for Neurog3creERT2; LSLNeurod1 respectively). The Muc2 + EGFP+ goblet cell numbers did not show significant difference upon conditional Neurod1 expression in Neurog3 progenitor cells (p = 0.25, Fig. 5A). We also crossed ROSA-LSLNeurod1 mice with the Neurog3-cre-ERT2 inducible cre driver line to temporally induce Neurod1 expression in Neurog3+ cells in adult mice. We observed a 35.5% increase in ChgA+ cells (p = 0.025), whereas a significant reduction of goblet cell number was seen (p = 0.002, Fig. 5B). The discrepancy of Neurod1 effect on goblet cell differentiation may depend on the timing of Neurod1 expression.
However, we did not observe EGFP-expression in Lyz+ Paneth cells (Fig. 5A). Consistent with what we observed in Neurog3-cre; LSLNeurod1 mice, we did not detect the presence of EGFP + Lyz + cells in the induced adult intestines (Fig. 5B). These data suggested that conditional Neurod1 expression in Neurog3 + secretory progenitors blocked their differentiation to Paneth cells in both developing and adult mice.
Discussion
Here we generated a new Neurod1 gain-of-function mouse line that enables conditional expression of Neurod1 in Cre expressing cells at different stages of EEC maturation. Whether the intestinal cells would respond to ectopic Neurod1 expression has not been examined. We reported here a substantial increase in the EEC numbers when Neurod1 was conditionally expressed in Villin-Cre+ intestinal cells. Expression of Neurod1 in Neurog3-Cre+ cells only led to a modest increase in EEC numbers whereas reduction in EEC numbers was seen in Neurod1-Cre+ cells. As with the recent findings of Neurod1 as a pioneer factor in the nervous system, our data suggest Neurod1 may function similarly in EEC differentiation and the effects are dependent on differentiation stage.
Sequential expression of bHLH transcription factor Neurogenin 3 and its target Neurod1 is a hallmark of enteroendocrine (EE) lineage specification and maturation. We first considered Neurog3+ EEC progenitors since Neurog3+ cells are multipotent early EEC progenitor cells46,57 that give rise to EEC, Goblet and Paneth cells, although majority of Goblet and Paneth cells arise from Gfi+ secretory progenitors. We observed that the expression of Neurod1 resulted in only ~2-fold increase of EEC numbers compared to WT, with no Neurod1 or ChgA epithelial ribbon staining. The increased EEC numbers may be from those Neurog3+ cells that fate to Paneth cells. Our data also suggested that EEC and Paneth cells arise at least in part from common progenitors, in line with recent lineage tracing experiments46.
Early lineage tracing in Villin-cre/ROSA26EGFP mice detected wide expression of EGFP throughout the whole intestinal epithelium, including all epithelial cells from intestinal stem cells at the crypt base and all types of matured epithelial cells. However, in the intestine of Villin-cre/LSLNeurod1 mice, approximately 30% to 39% of epithelial cells stained for Neurod1 (Fig. 1D), mostly detected in cells located in the crypt and lower villus (Fig. 1C). This may be due to the shorter half-life of Neurod1 leading to decreased Neurod1 along crypt-villus structure. The sensitivity of Neurod1 antibody used in Immunostaining may not be able to detect low levels of Neurod1. Neurod1+ ribbon structure can only be seen in ~10% of the whole intestine. A number of factors may contribute to such a discrepancy on the expression of transgenes between Vil-cre/L-Stop-LNeurod1 and Vil-cre/ROSA26R. Recent studies have shown that floxed alleles have different sensitivities to Cre-mediated recombination58. The recombination efficiency between different reporter alleles varies greatly on the nucleotide sequences flanking the LoxP sites, distance between loxP sites, the chromosomal location of floxed alleles and the levels of Cre activities.
Unlike normal EECs present as individual mucosal endocrine cells, the ChgA + epithelial ribbon structure in the intestines of Vil-cre+; LSLNeurod1 mice suggested certain Villin + Neurod1+ cells are stem cells. The Intestinal cell types including EECs arise from intestinal stem cells (ISCs) located at the crypt base. The existence of two stem cell pools in the intestinal crypt is well recognized: actively Lgr5+ cycling columnar basal cells (CBCs) and quiescent Bmi1+ +4 position slow cycling stem cells59,60. Bmi1+ cells have been suggested as pre-terminal enteroendocrine cells61. Intestinal stem cells in each pool are highly heterogeneous. In addition, other slow cycling stem cells have been identified to express other ISC markers such as Lrig162, Hopx63, mTert64. The identities and relationship of each type of stem cells with distinct ISC markers are not completely clear even after single-cell RNA sequencing of some progenitor pools that has defined hierarchical classification of some subpopulations46. Further studies to express Neurod1 in mouse intestine using different progenitor and stem cell marker specific Cre drivers such as Atoh165, Lgr566, Bmi160 and Lrig162 may shed more light on the identities of those Neurod1 susceptible early progenitor cells.
Similar to myogenic determining factor MyoD that trans-differentiate fibroblasts into functional skeletal muscle cells67–69, Neurod1 is able to direct neuron conversion from human cultured fibroblasts23 or in vivo endogenous mouse astrocytes in the brain and spinal cord70,71 when exogenously expressed. The interaction of Neurod1 with Atoh1 plays a role in neurosensory cell differentiation during inner ear development and regeneration37,72,73. The potential of Neurod1 to induce differentiation - including fate switching - in immature cells, suggests that it could play a major role in direct differentiation of cells, short-circuiting the current attempts to generate differentiated cells out of induced pluripotent stem cells. Consistent with this idea, recent studies showed that Neurod1 can function as a pioneer factor and its expression in microglia can directly convert microglia to functional neurons in the adult striatum47. Microglial cells are extremely plastic; it can undergo a variety of structure changes upon different stimuli. Like other pioneer factors, Neurod1 induces global transcriptional changes when exogenously expressed in microglia by occupying chromatin loci to modulate chromatin structure. Our preliminary results using a ChIP-seq assay identified over 7,500 substantial Neurod1 occupied loci in STC neuroendocrine cells (https://doi.org/10.1016/S0016-5085(17)30723-0), consistent with recent publication showing that nearly 3000 loci were regulated by Neurod174. Taken together, our data suggest a broader role of Neurod1 as a possible pioneer factor in EEC differentiation.
We previously showed by lineage tracing using Neurog3-cre;ROSA-EYFP mice that Neurog3+ cells gave rise to not only EEC, but also Goblet and Paneth cells57. Here we found that the gain-of-function of Neurod1 expression in Neurog3+ cells blocked Neurog3+ cells from differentiating into Paneth cells (Fig. 5). Similarly, when Neurod1 was expressed in Villin+ cells in Vilcre;LSLNeurod1 mice, we observed a considerable decrease in Paneth cell marker expression and no effect to Goblet and Tuft cell markers (Fig. 3). These results suggest that Neurod1 expression restricts intestinal epithelial cells towards EECs inhibiting Paneth cell lineage.
The canonical Wnt signaling pathway plays an important role not only in stem cell maintenance but also in Paneth cell differentiation and maturation processes75. Conditional expression of non-degradable mutant beta-catenin (exon3 deletion) in Neurod1+ EECs failed to activate wnt pathway, while the wnt activation occurred when the same mutant beta-catenin was expressed in Neurog3+ cells76. The onset of Neurod1 expression resulted in the failure of Wnt activation and inhibition of its target gene c-Myc expression76. In fact, a number of tissue specific transcription factors have been described to interact with β-catenin and inhibit Wnt activation in a number of developmental systems including chondrogenesis and hematopoiesis77–83. Those interactions lead to blocking of differentiation through disrupting β-catenin/TCF4 complex (Icat, Hif1a, Cdx2) or its binding to DNA (Runx3, Pdx1, Hbp1) or preventing coactivators recruitment (Klf4). Neurod1 might adopt similar mechanism in inhibiting Wnt activation. This may represent a novel yet unappreciated role of Neurod1 in mediating transcriptional repression of target gene expression.
Methods
Mice
The Institutional Animal Care and Use Committee (IACUC) at the University of Massachusetts Medical School approved all experimental protocols of our vertebrate animal studies in accordance with National Institute of Health (NIH) guidelines. All mice were housed in AALACC certified facilities, under constant temperature, air pressure and specific pathogen-free conditions and a 12-hour light cycle.
For lineage tracing experiments, we used previously described Cre-driver mouse lines including Vil-cre49, Neurog3-cre57, Neurog3-creERT2 and Neurod1-cre84. To induce Cre activity in Neurog3creERT2 compounded mice, 4-week old mice were treated with 2 mg tamoxifen (Sigma, T5648) dissolved in corn oil with one intraperitoneal injection daily for 5 consecutive days. Tissues were harvested and analyzed 7 days later.
Targeting loxp-neurod1-loxp ES cells
A pEntry-mNeurod1 plasmid was generated by cloning full-length mouse Neurod1 cDNA into the pEntry vector (Gateway). A Gateway-compatible pROSA26 Destination Vector (pROSA26-DV1 LMBP 6350)48 was used to generate a Rosa26 locus targeting vector for conditional overexpression of Neurod1 with an ires-EGFP reporter. Clones were verified by both enzymatic digestion and sequencing. A linearized ROSA26-DV1-mNeurod1 plasmid was electroporated into C57BL/6 derived JM8.F6 ES cells85. G418-resistant ES-cell clones were screened by PCR using primers set at both 5′ ROSA26 and 3′ covering loxP site: G1: 5′-TAGGTAGGGGATCGGGACTCT-3′; and G2: 5′-GCGAAGAGTTTGTCCTCAACC-3′ to generate a 1.3 kb fragment. PCR-positive clones were further verified with additional PCR reactions using both Neurod1 internal and external ROSA-3′UTR primers and EGFP primers as indicated in Fig. 1: S1: ATCATGTCTGGATCCCCATC; S2: GGGGCGGAATTCGATATCAAG. mND552rev: TGGTAGTGGGCTGGGACAAACCTTT. Rosa3′UTR-DV1-for: AACAGAGGCTGTTGGTACTAGTGGC; Rosa3′UTRrev: AGCACCAAATGTGGTGCAGT. EGFP-for: AAG TTC ATC TGC ACC ACC G; EGFPrev: TCC TTG AAG AAG ATG GTG CG.
Generation of chimeras
The chimeras were generated by our Transgenic Core facility (https://www.umassmed.edu/tkomouse/). In brief, obtained positive JM8.F6 ES cell clones were injected into albino C57BL/6Jtyrc-Brd blastocysts. The resulting chimeras were bred with Albino C57BL/6Jtyrc-Brd mice. Germline transmitted transgenic mice that carried targeted allele were selected by fur color and confirmed by genotyping using PCR analysis of DNA isolated from mice ear snips. Primer pairs S1:mND552rev shown in Fig. 1 were used in the PCR reaction.
Intestinal epithelial cell isolation
Mouse intestinal crypt and villus isolation were performed according to a published protocol with modifications86. In brief, mice were euthanized by CO2 and cervical dislocation. The small intestines were flushed with ice-cold 1xPBS and everted on a 4 mm rod. Intestinal tissues were cut into 2 cm pieces and incubated in chelating buffer [pH = 7.3: 1xD-PBS (1 mM CaCl2, 0.5 mM MgCl2, 8 mM Na2HPO4, 137 mM-NaCl, 1.5 mM-KH22PO4, 2.7 mM-KCl), 1 mM-DTT, 1 mM EDTA] at 4 °C with constant shaking for 30 min. The cells were released as large sheets of villus cells. The tissues were transferred to fresh chelating buffer and were vigorously shaken to release crypts into the media. The collected villus and crypt portions were filtered through a 70 µm Cell Strainer and pelleted at 200 rpm for 5 minutes with low brake speed. The villus and crypt pellets were resuspended in Trizol (Invitrogen, Inc.) for RNA extraction.
RNA isolation and qPCR analysis
RNAs were prepared with RNeasy Mini kit (Qiagen). In-column DNA digestion was performed to remove possible DNA contamination using RNase-free DNase (Qiagen). cDNAs were prepared using the Maxima First-Strand cDNA synthesis kit for RT-qPCR (Thermo Scientific). qPCRs were performed according to standard protocol using the Light Cycler (BioRad). Results are given as relative expression normalized to housekeeping gene beta-actin. Primer sequences are available upon request.
Immunofluorescence staining and western blotting
Intestinal tissues were fixed in 4% formaldehyde and embedded in OCT for frozen sections. For immunofluorescence analysis, the following primary antibodies were used: goat anti-EGFP (1:400, Novus Biologicals: NB100-1770), rabbit anti-Chromogranin A (1:1000, Immunostar: #20085), rabbit anti-Muc2 (1:500, Santa Cruz: H-300), and rabbit anti-Lyz (1:500, Zymed Laboratories: 18-0039), rabbit anti-Neurod1 (1:250, Abcam: Ab109224). Alexa Fluor 488 or 594 conjugated secondary antibodies were used at a dilution of 1:800. Intestinal Alkaline Phosphatase activities were detected according to the manufacturer’s protocol (Vector Red AP Substrate Kit, Cat. #: SK-5100). Images were aquired using a Nikon Eclipse E600 microscope with imaging software of NIS-Elements AR 4.30.02.
Western blotting was performed as previous describe22. In brief, equal amount of proteins was separated by SDS-PAGE and eleterotransferred onto a nitrocellulose membrane. Nonspecific binding to the membrane was blocked with a 3% milk solution in phosphate-buffered saline (PBS) containing 0.1% NP-40 prior to incubation with an anti-Neurod1 antibody (1:1,000; Abcam clone #Ab109224) or anti-actin antibody (1:2,000, Santa Cruz: sc-1616 HRP). An enhanced chemiluminescence (ECL) kit (Amersham) was used for detection of protein.
Statistical analysis
Pair-wise comparisons were analyzed by the Student’s t test. The statistical significance of pairwise comparisons shown on the bar graph were indicated with P ≤ 0.05 as significant and P > 0.05 as non-significant.
Supplementary information
Acknowledgements
The authors thank the transgenic core facility at UMASS Med school and Dr. Junhao Mao and Mrs. Melanie Trombly for critical reading and manuscript editing. This work was in part supported by NIH (R01 DK100223 and R01 DK110614 to AR; R01 AG060504 to BF).
Author contributions
H.J.L. and A.B.L. conceived the project, H.J.L. generated the transgenic mice, H.J.L. and S.R. performed the experiments and collected the data, J.H. and N.P. provided plasmids for generating conditional mNeurod1 targeting vector. H.J.L., A.L. and B.F. wrote the paper.
Data availability
No datasets were generated or analyzed during the current study.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-019-55292-7.
References
- 1.de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cellular and molecular life sciences: CMLS. 2003;60:1322–1332. doi: 10.1007/s00018-003-2289-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Noah TK, Donahue B, Shroyer NF. Intestinal development and differentiation. Experimental cell research. 2011;317:2702–2710. doi: 10.1016/j.yexcr.2011.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294:2155–2158. doi: 10.1126/science.1065718. [DOI] [PubMed] [Google Scholar]
- 4.Shroyer NF, Wallis D, Venken KJ, Bellen HJ, Zoghbi HY. Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes & development. 2005;19:2412–2417. doi: 10.1101/gad.1353905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Noah TK, Kazanjian A, Whitsett J, Shroyer NF. SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Experimental cell research. 2010;316:452–465. doi: 10.1016/j.yexcr.2009.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lopez-Diaz L, et al. Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Developmental biology. 2007;309:298–305. doi: 10.1016/j.ydbio.2007.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Li HJ, Ray SK, Singh NK, Johnston B, Leiter AB. Basic helix-loop-helix transcription factors and enteroendocrine cell differentiation. Diabetes Obes Metab. 2011;13(Suppl 1):5–12. doi: 10.1111/j.1463-1326.2011.01438.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gracz AD, et al. Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates. Gastroenterology. 2018;155:1508–1523 e1510. doi: 10.1053/j.gastro.2018.07.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Gerbe F, et al. Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium. J Cell Biol. 2011;192:767–780. doi: 10.1083/jcb.201010127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Mutoh H, et al. The basic helix-loop-helix transcription factor BETA2/NeuroD is expressed in mammalian enteroendocrine cells and activates secretin gene expression. Proceedings of the National Academy of Sciences of the United States of America. 1997;94:3560–3564. doi: 10.1073/pnas.94.8.3560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Naya FJ, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes & development. 1997;11:2323–2334. doi: 10.1101/gad.11.18.2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gross S, et al. The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2. Development. 2016;143:2616–2628. doi: 10.1242/dev.130682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Desai S, et al. Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine. Developmental biology. 2008;313:58–66. doi: 10.1016/j.ydbio.2007.09.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wang YC, et al. Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocrine-related cancer. 2009;16:267–279. doi: 10.1677/ERC-08-0127. [DOI] [PubMed] [Google Scholar]
- 15.Gierl MS, Karoulias N, Wende H, Strehle M, Birchmeier C. The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes & development. 2006;20:2465–2478. doi: 10.1101/gad.381806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Du A, et al. Arx is required for normal enteroendocrine cell development in mice and humans. Developmental biology. 2012;365:175–188. doi: 10.1016/j.ydbio.2012.02.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Beucher A, et al. The homeodomain-containing transcription factors Arx and Pax4 control enteroendocrine subtype specification in mice. PloS one. 2012;7:e36449. doi: 10.1371/journal.pone.0036449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Terry NA, Walp ER, Lee RA, Kaestner KH, May CL. Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis. American journal of physiology. Gastrointestinal and liver physiology. 2014;307:G979–991. doi: 10.1152/ajpgi.00390.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hill ME, Asa SL, Drucker DJ. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol. 1999;13:1474–1486. doi: 10.1210/mend.13.9.0340. [DOI] [PubMed] [Google Scholar]
- 20.Naya FJ, Stellrecht CM, Tsai MJ. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes & development. 1995;9:1009–1019. doi: 10.1101/gad.9.8.1009. [DOI] [PubMed] [Google Scholar]
- 21.Gu C, et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab. 2010;11:298–310. doi: 10.1016/j.cmet.2010.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ray SK, Nishitani J, Petry MW, Fessing MY, Leiter AB. Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Molecular and cellular biology. 2003;23:259–271. doi: 10.1128/MCB.23.1.259-271.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Pang ZP, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476:220–223. doi: 10.1038/nature10202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wapinski OL, et al. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell. 2013;155:621–635. doi: 10.1016/j.cell.2013.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Vierbuchen T, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463:1035. doi: 10.1038/nature08797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Noda T, et al. Direct Reprogramming of Spiral Ganglion Non-neuronal Cells into Neurons: Toward Ameliorating Sensorineural Hearing Loss by Gene Therapy. Frontiers in cell and developmental biology. 2018;6:16. doi: 10.3389/fcell.2018.00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ochocinska M, Hitchcock P. NeuroD regulates proliferation of photoreceptor progenitors in the retina of the zebrafish. Mechanisms of development. 2009;126:128–141. doi: 10.1016/j.mod.2008.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mutoh H, Naya FJ, Tsai MJ, Leiter AB. The basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cells. Genes & development. 1998;12:820–830. doi: 10.1101/gad.12.6.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Farah MH, et al. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development. 2000;127:693–702. doi: 10.1242/dev.127.4.693. [DOI] [PubMed] [Google Scholar]
- 30.Hevner RF, Hodge RD, Daza RA, Englund C. Transcription factors in glutamatergic neurogenesis: conserved programs in neocortex, cerebellum, and adult hippocampus. Neuroscience research. 2006;55:223–233. doi: 10.1016/j.neures.2006.03.004. [DOI] [PubMed] [Google Scholar]
- 31.Miyata T, Maeda T, Lee JE. NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes & development. 1999;13:1647–1652. doi: 10.1101/gad.13.13.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Liu M, et al. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:865–870. doi: 10.1073/pnas.97.2.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Schwab MH, et al. Neuronal basic helix-loop-helix proteins (NEX and BETA2/Neuro D) regulate terminal granule cell differentiation in the hippocampus. J Neurosci. 2000;20:3714–3724. doi: 10.1523/JNEUROSCI.20-10-03714.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kim WY, et al. NeuroD-null mice are deaf due to a severe loss of the inner ear sensory neurons during development. Development. 2001;128:417–426. doi: 10.1242/dev.128.3.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jahan I, Pan N, Kersigo J, Fritzsch B. Neurod1 suppresses hair cell differentiation in ear ganglia and regulates hair cell subtype development in the cochlea. PLoS One. 2010;5:e11661. doi: 10.1371/journal.pone.0011661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Liu M, et al. Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems. Genes & development. 2000;14:2839–2854. doi: 10.1101/gad.840500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Macova I, et al. Neurod1 is essential for the primary tonotopic organization and related auditory information processing in the midbrain. Journal of Neuroscience. 2019;39:984–1004. doi: 10.1523/JNEUROSCI.2557-18.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rindi G, et al. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development. 1999;126:4149–4156. doi: 10.1242/dev.126.18.4149. [DOI] [PubMed] [Google Scholar]
- 39.Li HJ, et al. Distinct cellular origins for serotonin-expressing and enterochromaffin-like cells in the gastric corpus. Gastroenterology. 2014;146:754–764 e753. doi: 10.1053/j.gastro.2013.11.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Itkin-Ansari P, et al. NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor. Developmental dynamics: an official publication of the American Association of Anatomists. 2005;233:946–953. doi: 10.1002/dvdy.20443. [DOI] [PubMed] [Google Scholar]
- 41.Malecki MT, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nature genetics. 1999;23:323–328. doi: 10.1038/15500. [DOI] [PubMed] [Google Scholar]
- 42.Orosz O, et al. Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene. Mol Vis. 2015;21:124–130. [PMC free article] [PubMed] [Google Scholar]
- 43.Anderson KR, et al. Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3. The Journal of biological chemistry. 2009;284:31236–31248. doi: 10.1074/jbc.M109.048694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Huang HP, et al. Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3. Molecular and cellular biology. 2000;20:3292–3307. doi: 10.1128/MCB.20.9.3292-3307.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Haber AL, et al. A single-cell survey of the small intestinal epithelium. Nature. 2017;551:333–339. doi: 10.1038/nature24489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Gehart H, et al. Identification of Enteroendocrine Regulators by Real-Time Single-Cell Differentiation Mapping. Cell. 2019;176:1158–1173 e1116. doi: 10.1016/j.cell.2018.12.029. [DOI] [PubMed] [Google Scholar]
- 47.Matsuda T, et al. Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion. Neuron. 2019;101:472–485 e477. doi: 10.1016/j.neuron.2018.12.010. [DOI] [PubMed] [Google Scholar]
- 48.Nyabi O, et al. Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells. Nucleic acids research. 2009;37:e55. doi: 10.1093/nar/gkp112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.el Marjou F, et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193. doi: 10.1002/gene.20042. [DOI] [PubMed] [Google Scholar]
- 50.Madison BB, et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. The Journal of biological chemistry. 2002;277:33275–33283. doi: 10.1074/jbc.M204935200. [DOI] [PubMed] [Google Scholar]
- 51.Houdebine LM, Attal J. Internal ribosome entry sites (IRESs): reality and use. Transgenic research. 1999;8:157–177. doi: 10.1023/A:1008909908180. [DOI] [PubMed] [Google Scholar]
- 52.Taboit-Dameron F, et al. Association of the 5′HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits. Transgenic research. 1999;8:223–235. doi: 10.1023/A:1008919925303. [DOI] [PubMed] [Google Scholar]
- 53.Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev. 1991;12:181–187. doi: 10.1210/edrv-12-2-181. [DOI] [PubMed] [Google Scholar]
- 54.Jensen J, et al. Control of endodermal endocrine development by Hes-1. Nature genetics. 2000;24:36–44. doi: 10.1038/71657. [DOI] [PubMed] [Google Scholar]
- 55.Pan N, Jahan I, Lee JE, Fritzsch B. Defects in the cerebella of conditional Neurod1 null mice correlate with effective Tg (Atoh1-cre) recombination and granule cell requirements for Neurod1 for differentiation. Cell and tissue research. 2009;337:407–428. doi: 10.1007/s00441-009-0826-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Jahan I, Pan N, Elliott KL, Fritzsch B. The quest for restoring hearing: understanding ear development more completely. Bioessays. 2015;37:1016–1027. doi: 10.1002/bies.201500044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Schonhoff SE, Giel-Moloney M, Leiter AB. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Developmental biology. 2004;270:443–454. doi: 10.1016/j.ydbio.2004.03.013. [DOI] [PubMed] [Google Scholar]
- 58.Liu J, et al. Non-parallel recombination limits Cre-LoxP-based reporters as precise indicators of conditional genetic manipulation. Genesis. 2013;51:436–442. doi: 10.1002/dvg.22384. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Li L, Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science. 2010;327:542–545. doi: 10.1126/science.1180794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nature genetics. 2008;40:915–920. doi: 10.1038/ng.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Jadhav U, et al. Dynamic Reorganization of Chromatin Accessibility Signatures during Dedifferentiation of Secretory Precursors into Lgr5+ Intestinal Stem Cells. Cell stem cell. 2017;21:65–77 e65. doi: 10.1016/j.stem.2017.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Ordonez-Moran P, Huelsken J. Lrig1: a new master regulator of epithelial stem cells. The EMBO journal. 2012;31:2064–2066. doi: 10.1038/emboj.2012.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Takeda N, et al. Interconversion between intestinal stem cell populations in distinct niches. Science. 2011;334:1420–1424. doi: 10.1126/science.1213214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Breault DT, et al. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:10420–10425. doi: 10.1073/pnas.0804800105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.VanDussen KL, Samuelson LC. Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate. Developmental biology. 2010;346:215–223. doi: 10.1016/j.ydbio.2010.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Barker N, Clevers H. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 2010;138:1681–1696. doi: 10.1053/j.gastro.2010.03.002. [DOI] [PubMed] [Google Scholar]
- 67.Weintraub H, et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proceedings of the National Academy of Sciences. 1989;86:5434–5438. doi: 10.1073/pnas.86.14.5434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Lahmann, I. et al. Oscillations of MyoD and Hes1 proteins regulate the maintenance of activated muscle stem cells. Genes & development (2019). [DOI] [PMC free article] [PubMed]
- 69.Boularaoui SM, et al. Efficient transdifferentiation of human dermal fibroblasts into skeletal muscle. Journal of tissue engineering and regenerative medicine. 2018;12:e918–e936. doi: 10.1002/term.2415. [DOI] [PubMed] [Google Scholar]
- 70.Brulet R, Zhu J, Aktar M, Hsieh J, Cho KO. Mice with conditional NeuroD1 knockout display reduced aberrant hippocampal neurogenesis but no change in epileptic seizures. Exp Neurol. 2017;293:190–198. doi: 10.1016/j.expneurol.2017.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Su Z, Niu W, Liu ML, Zou Y, Zhang CL. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nature communications. 2014;5:3338. doi: 10.1038/ncomms4338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Pan N, Jahan I, Lee JE, Fritzsch B. Defects in the cerebella of conditional Neurod1 null mice correlate with effective Tg(Atoh1-cre) recombination and granule cell requirements for Neurod1 for differentiation. Cell Tissue Res. 2009;337:407–428. doi: 10.1007/s00441-009-0826-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Jahan I, Elliott KL, Fritzsch B. Understanding Molecular Evolution and Development of the Organ of Corti Can Provide Clues for Hearing Restoration. Integr Comp Biol. 2018;58:351–365. doi: 10.1093/icb/icy019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Pataskar A, et al. NeuroD1 reprograms chromatin and transcription factor landscapes to induce the neuronal program. The EMBO journal. 2016;35:24–45. doi: 10.15252/embj.201591206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes & development. 2005;19:877–890. doi: 10.1101/gad.1295405. [DOI] [PubMed] [Google Scholar]
- 76.Wang Y, Giel-Moloney M, Rindi G, Leiter AB. Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin. Proceedings of the National Academy of Sciences of the United States of America. 2007;104:11328–11333. doi: 10.1073/pnas.0702665104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Evans PM, Chen X, Zhang W, Liu C. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Molecular and cellular biology. 2010;30:372–381. doi: 10.1128/MCB.00063-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Ito K, et al. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell. 2008;14:226–237. doi: 10.1016/j.ccr.2008.08.004. [DOI] [PubMed] [Google Scholar]
- 79.Chen L, et al. Negative regulation of c-Myc transcription by pancreas duodenum homeobox-1. Endocrinology. 2007;148:2168–2180. doi: 10.1210/en.2006-1221. [DOI] [PubMed] [Google Scholar]
- 80.Guo, R. J., Funakoshi, S., Lee, H. H., Kong, J. & Lynch, J. P. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis31, 159–166. [DOI] [PMC free article] [PubMed]
- 81.Lim JH, Chun YS, Park JW. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Cancer Res. 2008;68:5177–5184. doi: 10.1158/0008-5472.CAN-07-6234. [DOI] [PubMed] [Google Scholar]
- 82.Sampson EM, et al. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. The EMBO journal. 2001;20:4500–4511. doi: 10.1093/emboj/20.16.4500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Zhang K, et al. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/beta-catenin activity. Cancer Lett. 2015;357:404–411. doi: 10.1016/j.canlet.2014.11.047. [DOI] [PubMed] [Google Scholar]
- 84.Li HJ, Kapoor A, Giel-Moloney M, Rindi G, Leiter AB. Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine. Developmental biology. 2012;371:156–169. doi: 10.1016/j.ydbio.2012.08.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Pettitt SJ, et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nature methods. 2009;6:493–495. doi: 10.1038/nmeth.1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Flint N, Cove FL, Evans GS. A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis. Biochem J. 1991;280(Pt 2):331–334. doi: 10.1042/bj2800331. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
No datasets were generated or analyzed during the current study.